| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |